Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancer

(MedPage Today) -- Metastasis-directed therapy (MDT) in selected patients with recurrent oligometastatic prostate cancer led to PSA responses in a majority of patients and delayed initiation of hormonal therapy by 18 months, a retrospective study...
Source: MedPage Today Radiology - Category: Radiology Source Type: news